메뉴 건너뛰기




Volumn 5, Issue 5, 2014, Pages 340-345

Interaction between prion protein and Aβ amyloid fibrils revisited

Author keywords

Alzheimer's disease; amyloid fibrils; A peptide; Prion protein

Indexed keywords

AMYLOID BETA PROTEIN; BINDING PROTEIN; OLIGOMER; PRION PROTEIN; PRION; PROTEIN BINDING;

EID: 84901260237     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn500019c     Document Type: Article
Times cited : (26)

References (26)
  • 1
    • 0035066332 scopus 로고    scopus 로고
    • Alzheimer's disease: Genes, proteins, and therapy
    • Selkoe, D. J. (2001) Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81, 741-766
    • (2001) Physiol. Rev. , vol.81 , pp. 741-766
    • Selkoe, D.J.1
  • 2
    • 0024990330 scopus 로고
    • Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides
    • Yankner, B. A., Duffy, L. K., and Kirschner, D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides Science 250, 279-282
    • (1990) Science , vol.250 , pp. 279-282
    • Yankner, B.A.1    Duffy, L.K.2    Kirschner, D.A.3
  • 3
    • 0025733411 scopus 로고
    • Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures
    • Pike, C. J., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1991) Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures Eur. J. Pharmacol. 207, 367-368
    • (1991) Eur. J. Pharmacol. , vol.207 , pp. 367-368
    • Pike, C.J.1    Walencewicz, A.J.2    Glabe, C.G.3    Cotman, C.W.4
  • 4
    • 0028172886 scopus 로고
    • Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
    • Lorenzo, A. and Yankner, B. A. (1994) Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red Proc. Natl. Acad. Sci. U.S.A. 91, 12243-12247
    • (1994) Proc. Natl. Acad. Sci. U.S.A. , vol.91 , pp. 12243-12247
    • Lorenzo, A.1    Yankner, B.A.2
  • 5
    • 0026604096 scopus 로고
    • Deposition of amyloid beta protein in non-Alzheimer dementias: Evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease
    • Mann, D. M., Jones, D., South, P. W., Snowden, J. S., and Neary, D. (1992) Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease Acta Neuropathol. 83, 415-419
    • (1992) Acta Neuropathol. , vol.83 , pp. 415-419
    • Mann, D.M.1    Jones, D.2    South, P.W.3    Snowden, J.S.4    Neary, D.5
  • 7
    • 34248190279 scopus 로고    scopus 로고
    • Abeta oligomers - A decade of discovery
    • Walsh, D. M. and Selkoe, D. J. (2007) Abeta oligomers-a decade of discovery J. Neurochem. 101, 1172-1184
    • (2007) J. Neurochem. , vol.101 , pp. 1172-1184
    • Walsh, D.M.1    Selkoe, D.J.2
  • 8
    • 0035297712 scopus 로고    scopus 로고
    • Targeting small Abeta oligomers: The solution to an Alzheimer's disease conundrum?
    • Klein, W. L., Krafft, G. A., and Finch, C. E. (2001) Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224
    • (2001) Trends Neurosci. , vol.24 , pp. 219-224
    • Klein, W.L.1    Krafft, G.A.2    Finch, C.E.3
  • 9
    • 33847662852 scopus 로고    scopus 로고
    • Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide
    • Haass, C. and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat. Rev. Mol. Cell Biol. 8, 101-112
    • (2007) Nat. Rev. Mol. Cell Biol. , vol.8 , pp. 101-112
    • Haass, C.1    Selkoe, D.J.2
  • 10
    • 0037200117 scopus 로고    scopus 로고
    • Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability
    • Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability J. Biol. Chem. 277, 32046-32053
    • (2002) J. Biol. Chem. , vol.277 , pp. 32046-32053
    • Dahlgren, K.N.1    Manelli, A.M.2    Stine, Jr.W.B.3    Baker, L.K.4    Krafft, G.A.5    Ladu, M.J.6
  • 11
    • 61349201380 scopus 로고    scopus 로고
    • Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers
    • Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers Nature 457, 1128-1132
    • (2009) Nature , vol.457 , pp. 1128-1132
    • Lauren, J.1    Gimbel, D.A.2    Nygaard, H.B.3    Gilbert, J.W.4    Strittmatter, S.M.5
  • 17
    • 77956197815 scopus 로고    scopus 로고
    • Interaction between human prion protein and amyloid-beta (Abeta) oligomers: Role of N-terminal residues
    • Chen, S., Yadav, S. P., and Surewicz, W. K. (2010) Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues J. Biol. Chem. 285, 26377-26383
    • (2010) J. Biol. Chem. , vol.285 , pp. 26377-26383
    • Chen, S.1    Yadav, S.P.2    Surewicz, W.K.3
  • 20
    • 84866930442 scopus 로고    scopus 로고
    • Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity
    • Nieznanski, K., Choi, J. K., Chen, S., Surewicz, K., and Surewicz, W. K. (2012) Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity J. Biol. Chem. 287, 33104-33108
    • (2012) J. Biol. Chem. , vol.287 , pp. 33104-33108
    • Nieznanski, K.1    Choi, J.K.2    Chen, S.3    Surewicz, K.4    Surewicz, W.K.5
  • 21
    • 84877144645 scopus 로고    scopus 로고
    • The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers
    • Younan, N. D., Sarell, C. J., Davies, P., Brown, D. R., and Viles, J. H. (2013) The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers FASEB J. 27, 1847-1858
    • (2013) FASEB J. , vol.27 , pp. 1847-1858
    • Younan, N.D.1    Sarell, C.J.2    Davies, P.3    Brown, D.R.4    Viles, J.H.5
  • 23
    • 1842766124 scopus 로고    scopus 로고
    • Molecular basis of barriers for interspecies transmissibility of mammalian prions
    • Vanik, D. L., Surewicz, K. A., and Surewicz, W. K. (2004) Molecular basis of barriers for interspecies transmissibility of mammalian prions Mol. Cell 14, 139-145
    • (2004) Mol. Cell , vol.14 , pp. 139-145
    • Vanik, D.L.1    Surewicz, K.A.2    Surewicz, W.K.3
  • 24
    • 84863396434 scopus 로고    scopus 로고
    • Aggregate reactivation mediated by the Hsp100 chaperones
    • Zolkiewski, M., Zhang, T., and Nagy, M. (2012) Aggregate reactivation mediated by the Hsp100 chaperones Arch. Biochem. Biophys. 520, 1-6
    • (2012) Arch. Biochem. Biophys. , vol.520 , pp. 1-6
    • Zolkiewski, M.1    Zhang, T.2    Nagy, M.3
  • 25
    • 0033601248 scopus 로고    scopus 로고
    • Membrane environment alters the conformational structure of the recombinant human prion protein
    • Morillas, M., Swietnicki, W., Gambetti, P., and Surewicz, W. K. (1999) Membrane environment alters the conformational structure of the recombinant human prion protein J. Biol. Chem. 274, 36859-36865
    • (1999) J. Biol. Chem. , vol.274 , pp. 36859-36865
    • Morillas, M.1    Swietnicki, W.2    Gambetti, P.3    Surewicz, W.K.4
  • 26
    • 0038176528 scopus 로고    scopus 로고
    • In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis
    • Stine, W. B., Jr., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis J. Biol. Chem. 278, 11612-11622
    • (2003) J. Biol. Chem. , vol.278 , pp. 11612-11622
    • Stine, Jr.W.B.1    Dahlgren, K.N.2    Krafft, G.A.3    Ladu, M.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.